Investors
For every euro invested, €5.19 in healthcare and societal costs has been prevented. That figure is measured across our portfolio since 2018. Three funds, 19 companies and one conviction: solving a real healthcare problem creates value for investors and for society at the same time.
What we bring to the table
Reimbursement
Market Access
Clinical Validation
Insurers and Hospitals
Follow-on Capital
Evidence is our competitive advantage
Impact in healthcare investing is measurable. We prove it.
We measure our impact
The LIFe Impact Framework was developed by Invest-NL, PGGM, Achmea IM, VGZ and CbusineZ as the first shared standard for measuring societal impact in healthcare investments. We are the first fund to apply it across an entire portfolio and publish the results. If we cannot substantiate a number, it does not appear in our report.
Impact is built into how we are paid
Carried interest is linked to what we deliver, not only to financial return. An independent impact board monitors that throughout the life of the fund.
We invest only in early-stage digital health
Since 2018, without exception. Three funds, 19 companies, one sector. That focus is why founders come to us before they go anywhere else, and why we recognise a reimbursement problem six months before it appears.
Returns and impact reinforce each other
Solving a real healthcare problem creates economic value for society. If it does not, the model does not work at scale. That assumption is why we exist, and we publish the numbers that test it.
Proven track record since 2018
3
Active funds, €42M raised
€80M
Follow-on capital raised by our portfolio
19
Companies backed
85
Clinical studies completed and ongoing
5
Companies reimbursed by Dutch health insurers
2
Exits to date
.jpg)
Let's talk about collaboration.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
